PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹100 Cr | ₹61 Cr | ₹57 Cr | ₹45 Cr | ₹30 Cr |
What is the latest Contingent Liabilities ratio of PIRAMAL PHARMA ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹100 Cr |
Mar2024 | ₹61 Cr |
Mar2023 | ₹57 Cr |
Mar2022 | ₹45 Cr |
Mar2021 | ₹30 Cr |
How is Contingent Liabilities of PIRAMAL PHARMA Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹100 Cr | 62.40 | |
Mar2024 | ₹61 Cr | 7.17 | |
Mar2023 | ₹57 Cr | 27.55 | |
Mar2022 | ₹45 Cr | 49.90 | |
Mar2021 | ₹30 Cr | - |
Compare Contingent Liabilities of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹26,690.3 Cr | 6.9% | 3.8% | 3.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,622.0 Cr | 2% | -2.3% | -12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,536.0 Cr | -1.3% | -6.2% | 21.2% | Stock Analytics | |
CIPLA | ₹125,468.0 Cr | -2.2% | 3.6% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,162.0 Cr | -0% | -0.3% | 5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,874.0 Cr | -0.9% | 4.5% | -8.6% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | 6.9% |
3.8% |
3.1% |
SENSEX | 1.1% |
-0.4% |
-2.2% |
You may also like the below Video Courses